---
figid: PMC5056381__srep34284-f8
figtitle: The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule
  and the underlying signaling mechanisms in a rat model of diabetes mellitus
organisms:
- NA
pmcid: PMC5056381
filename: srep34284-f8.jpg
figlink: /pmc/articles/PMC5056381/figure/f8/
number: F8
caption: DMC is an effective strategy to lower blood glucose by upregulating the GLP-1
  and GIP secretion and increase the GCG, GIP transcription by enhancing the TCF7L2
  expression through the GSK-3β/β-catenin pathway.
papertitle: The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule
  and the underlying signaling mechanisms in a rat model of diabetes mellitus.
reftext: Yong Zhang, et al. Sci Rep. 2016;6:34284.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9525443
figid_alias: PMC5056381__F8
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5056381__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5056381__srep34284-f8.html
  '@type': Dataset
  description: DMC is an effective strategy to lower blood glucose by upregulating
    the GLP-1 and GIP secretion and increase the GCG, GIP transcription by enhancing
    the TCF7L2 expression through the GSK-3β/β-catenin pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GIP
  - GNAI2
  - C1QTNF1
  - GCG
  - GLP1R
  - ZGLP1
  - GSK3B
  - CTNNB1
  - TCF7L2
  - glucose
---
